Fund HoldingsPatient Square Capital LP

Total Portfolio Value
$241.72M
Total Bought
$29.40M
Total Sold
$17.23M
Net Transaction
+$12.17M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
INSMED INC(INSM)307,167330,250+23,08321,20725,19510.42%+3,988
KYMERA THERAPEUTICS, INC.(KYMR)0142,201+142,20103,8921.61%+3,892
SCHOLAR ROCK HOLDING CORPORATION(SRRK)32,000154,000+122,0001,3834,9512.05%+3,568
BLUEPRINT MEDICINES CORPORATION038,500+38,50003,4081.41%+3,408
OCULAR THERAPEUTIX, INC.(OCUL)470,919920,199+449,2804,0226,7452.79%+2,723
MIRUM PHARMACEUTICALS, INC.(MIRM)64,900116,362+51,4622,6845,2422.17%+2,558
SOLENO THERAPEUTICS, INC.018,600+18,60001,3290.55%+1,329
LIQUIDIA CORPORATION(LQDA)1,860,3711,522,452-337,91921,87822,4569.29%+578
DISC MEDICINE, INC.(IRON)56,40083,000+26,6003,5764,1201.70%+544
VYNE THERAPEUTICS INC.0257,033+257,03304060.17%+406
ALLOGENE THERAPEUTICS, INC.1,489,9092,368,186+878,2773,1743,4581.43%+284
AGIOS PHARMACEUTICALS, INC.(AGIO)121,732139,732+18,0004,0004,0941.69%+94
ENLIVEN THERAPEUTICS, INC.224,038253,838+29,8005,0414,9962.07%-45
PHARVARIS N. V.
COM
207,603245,496+37,8933,9803,8541.59%-125
INTELLIA THERAPEUTICS, INC.(NTLA)215,981232,781+16,8002,5181,6550.68%-863
ASTRIA THERAPEUTICS INC105,0570-105,0579390-939
ARVINAS, INC.86,6270-86,6271,6610-1,661
EYEPOINT PHARMACEUTICALS, INC.(EYPT)1,410,3311,481,977+71,64610,5078,0323.32%-2,475
NURIX THERAPEUTICS, INC.(NRIX)446,296447,296+1,0008,4085,3142.20%-3,094
SPRINGWORKS THERAPEUTICS, INC.93,1370-93,1373,3650-3,365
CULLINAN THERAPEUTICS, INC.(CGEM)878,897878,897010,7056,6532.75%-4,052
GERON CORPORATION(GERN)1,321,2680-1,321,2684,6770-4,677
INTRA-CELLULAR THERAPIES INC.71,9900-71,9906,0130-6,013
ROIVANT SCIENCES LTD.(ROIV)12,480,00012,480,0000147,638125,92352.09%-21,715
Page 1 of 1